Abstract:Objective To investigate the correlation between the levels of placenta growth factor (PLGF),soluble angiopoietin receptor-2 (sTie-2) and critical coronary artery plaque imaging morphology of coronary borderline lesions in patients with coronary heart disease (CHD).Methods In three consecutive years from April 2007 to September 2009,a cohort of 719 patients with borderline coronary lesions with stenosis in three main vessels with lumen diameter reduction varied all the way from more than 20％ to less than 70％ and with greater than 2.25 mm of the inner diameter were selected in this study from 4 teaching hospitals of tertiary class A in Beijing.These patients fell into three categories:unstable angina pectoris (UAP,n =292),stable angina pectoris (SAP,n =219) and coronary arteriosclerosis (AS,n =208).The vessels involved were analyzed using quantitative coronary angiography (QCA).Plasma levels of PLGF and sTie-2 were measured by using protein chip.The relationship between plasma levels of vascular factors,sTie-2,PLGF and coronary artery plaque imaging morphology among three groups were analyzed.Results (1) Plasma level of PLGF was 80.33 ng/L in the UAP group,which was significantly higher than 54.29 ng/L in the SAP group and 45.16 ng/L in AS group (both P ＜0.05).Plasma level of sTie-2 was 1353.06 ng/L in the UAP group,which was significantly higher than 1308.28 ng/L in the AS group (P =0.008).(2) There was significantly statistical differences in QCA between the SAP group and the UAP group as well as the AS group (both P ＜ 0.05) in terms of the minimal lumen diameter,diameter stenosis rate,minimal lumen cross-sectional area and cross-sectional area of stenosis.The plaque area in the UAP group was larger than that in the AS group (P =0.013).(3) The relationship between vascular factors and plaque imaging morphology was analyzed.There was significantly statistical difference in the involved lesions among the three groups (P ＜ 0.01).(4) There was a positive correlation between plasma level of PLGF and minimal lumen cross-sectional area (r =0.493,P =0.009).Conclusions The plasma levels of PLGF and sTie-2 reflect the level of neo-vascularization in the plaque,and could be taken as predictive factors for potential pathogenesis of coronary plaque.

Increased serum level of soluble vascular endothelial growth factor receptor-1 is associated with poor coronary collateralization in patients with stable coronary artery disease.

GW26-e5439 Increased Serum Level of Soluble VEGF Receptor-1 is Associated with Low Coronary Collateralization in Patients with Stable Coronary Artery Disease

An Elevated Level of BNP in Plasma is Related to the Development of Good Collateral Circulation in Coronary Artery Disease

Relationship Between Serum Thymosin Β4 Levels and Coronary Collateral Development

Plasma Hyaluronan and Collateral Development in Patients with Coronary Artery Disease

Study on the Relationship between Soluble Receptor for Advanced Glycation end Products and Coronary Artery Disease in Nondiabetic Patients

SerpinG1: A Novel Biomarker Associated With Poor Coronary Collateral in Patients With Stable Coronary Disease and Chronic Total Occlusion.

Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion

Clinical and Angiographic Features Associated with Coronary Collateralization in Stable Angina Patients with Chronic Total Occlusion

Relationship between Myocardial Collateral Vessel Formation and the Levels of Hypoxia-Inducible Factor 1-alpha and Vascular Endothelial Growth Factor A and Its Clinical Significance

The preservation effect of coronary collateral circulation on left ventricular function in chronic total occlusion and its association with the expression of vascular endothelial growth factor A.

Reduced Plasma Mir-146A is a Predictor of Poor Coronary Collateral Circulation in Patients with Coronary Artery Disease.

The Relationship of Plasma Decoy Receptor 3 and Coronary Collateral Circulation in Patients with Coronary Artery Disease

Reiation between serum giycated aibumin ievei and coronary coiiaterais in type 2 diabetic patients

Lipoprotein (a) Interactions with Cholesterol-Containing Lipids on Angiographic Coronary Collateralization in Type 2 Diabetic Patients with Chronic Total Occlusion

Growth Differentiation Factor 15 and Coronary Collateral Formation

Correlation Between Angiopoietin-1, Angiopoietin-2 and Coronary Collateral Circulation Formation in Patients with Coronary Heart Disease

A study in the correlation between vascular factors and plaque imaging morphology of coronary borderline lesions in patients with coronary heart disease

Abstract 1742: Expression of the Anti-Angiogenic Proteins Angiostatin and Endostatin is Increased in Diabetic Patients and Associated with Impaired Coronary Collateral Formation

Relationship between thrombospondin-1, endostatin, angiopoietin-2, and coronary collateral development in patients with chronic total occlusion.

Diabetic dyslipidemia impairs coronary collateral formation: An update